Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Sulbactam Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 134Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2ENTASIS THERAP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    ENTASIS THERAP

    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      NCE
      2028-05-23
      216974
      1
      blank

      01

      ENTASIS THERAP

      DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

      arrow
      The Generic Rx Session
      Not Confirmed

      ENTASIS THERAP

      U.S.A
      arrow
      The Generic Rx Session
      Not Confirmed

      DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

      Exclusivity Code : NCE

      Exclusivity Expiration Date : 2028-05-23

      Application Number : 216974

      Product Number : 1

      Exclusivity Details :

      blank

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      ENTASIS THERAP

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

        Portfolio PDF

        Product Web Link

        Virtual Booth

        Digital Content

        Website

        Corporate PDF

        GAIN
        2033-05-23
        216974
        1
        blank

        02

        ENTASIS THERAP

        DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

        arrow
        PharmScience R&D
        Not Confirmed